Sunday, November 3, 2024
HomeTagsLIVMARLI

LIVMARLI

Mirum Submits for European Approval of LIVMARLI in Progressive Familial Intrahepatic Cholestasis

Mirum Pharmaceuticals, Inc. announced submission to the European Medicines Agency (EMA) of a variation application to the Marketing Authorization for LIVMARLI (maralixibat) oral solution,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics